Roche P/E is discounted vs its historical average. All in all, Roche maintained its growth path with sales up 1% to CHF 63.28 billion. Looking at the division, pharmaceutical sales increased by 2% to …
Read Full Story at source (may require registration)
Latest posts by CHF Editor (see all)
- Technical talk: EUR/CHF rejecting monthly resistance - January 24, 2024
- USD/CHF moves higher to near 0.8680 as Fed members maintain a hawkish stance - January 24, 2024
- Holcim price target lowered by CHF 2 at Barclays - January 24, 2024